Rite Aid (RAD) Tops Q3 EPS by 1c, Updates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
Go back to Rite Aid (RAD) Tops Q3 EPS by 1c, Updates FY Guidance
December 21, 2018 7:25 AM EST
JPMorgan analyst, Lisa Gill, reiterated a Neutral rating on Rite-Aid (NYSE: RAD) following the company's 3Q earnings report. Adjusted EBITDA was $13M above forecasts, with upside driven mainly on the gross profit line. Adjusted EPS of +$0.01 compared to estimates of -$0.01.
In the retail... More
December 19, 2018 4:16 PM EST
Rite Aid Corporation (NYSE: RAD) and McKesson Corporation (NYSE: MCK) announced an agreement to key terms that will continue the companies pharmaceutical sourcing and distribution partnership for an additional 10 years. Under these terms, McKesson will continue providing Rite Aid with sourcing and direct-to-store delivery for brand and generic pharmaceutical products through March 2029.
Rite Aid and McKesson have a long history as trusted partners in ensuring the availability of essential medications to patients. The new terms create efficiencies and opportunities for future growth by leveraging the... More
